These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 17292610
21. Fragmentation of GW4064 led to a highly potent partial farnesoid X receptor agonist with improved drug-like properties. Flesch D, Gabler M, Lill A, Gomez RC, Steri R, Schneider G, Stark H, Schubert-Zsilavecz M, Merk D. Bioorg Med Chem; 2015 Jul 01; 23(13):3490-8. PubMed ID: 25934227 [Abstract] [Full Text] [Related]
22. FXR-mediated regulation of angiotensin type 2 receptor expression in vascular smooth muscle cells. Zhang Q, He F, Kuruba R, Gao X, Wilson A, Li J, Billiar TR, Pitt BR, Xie W, Li S. Cardiovasc Res; 2008 Feb 01; 77(3):560-9. PubMed ID: 18006431 [Abstract] [Full Text] [Related]
25. FXR-mediated regulation of eNOS expression in vascular endothelial cells. Li J, Wilson A, Kuruba R, Zhang Q, Gao X, He F, Zhang LM, Pitt BR, Xie W, Li S. Cardiovasc Res; 2008 Jan 01; 77(1):169-77. PubMed ID: 18006476 [Abstract] [Full Text] [Related]
29. Identification of an N-oxide pyridine GW4064 analog as a potent FXR agonist. Feng S, Yang M, Zhang Z, Wang Z, Hong D, Richter H, Benson GM, Bleicher K, Grether U, Martin RE, Plancher JM, Kuhn B, Rudolph MG, Chen L. Bioorg Med Chem Lett; 2009 May 01; 19(9):2595-8. PubMed ID: 19328688 [Abstract] [Full Text] [Related]
30. Discovery of sulfated sterols from marine invertebrates as a new class of marine natural antagonists of farnesoid-X-receptor. Sepe V, Bifulco G, Renga B, D'Amore C, Fiorucci S, Zampella A. J Med Chem; 2011 Mar 10; 54(5):1314-20. PubMed ID: 21309576 [Abstract] [Full Text] [Related]
33. Discovery of XL335 (WAY-362450), a highly potent, selective, and orally active agonist of the farnesoid X receptor (FXR). Flatt B, Martin R, Wang TL, Mahaney P, Murphy B, Gu XH, Foster P, Li J, Pircher P, Petrowski M, Schulman I, Westin S, Wrobel J, Yan G, Bischoff E, Daige C, Mohan R. J Med Chem; 2009 Feb 26; 52(4):904-7. PubMed ID: 19159286 [Abstract] [Full Text] [Related]
34. Is antagonism of E/Z-guggulsterone at the farnesoid X receptor mediated by a noncanonical binding site? A molecular modeling study. Meyer U, Costantino G, Macchiarulo A, Pellicciari R. J Med Chem; 2005 Nov 03; 48(22):6948-55. PubMed ID: 16250653 [Abstract] [Full Text] [Related]
35. Pyrrole[2,3-d]azepino compounds as agonists of the farnesoid X receptor (FXR). Mehlmann JF, Crawley ML, Lundquist JT, Unwalla RJ, Harnish DC, Evans MJ, Kim CY, Wrobel JE, Mahaney PE. Bioorg Med Chem Lett; 2009 Sep 15; 19(18):5289-92. PubMed ID: 19683924 [Abstract] [Full Text] [Related]
36. Discovery of new non-steroidal farnesoid X receptor modulators through 3D shape similarity search and structure-based virtual screening. Wang L, Si P, Sheng Y, Chen Y, Wan P, Shen X, Tang Y, Chen L, Li W. Chem Biol Drug Des; 2015 Apr 15; 85(4):481-7. PubMed ID: 25228339 [Abstract] [Full Text] [Related]